In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

BioXell grosses €17mm with Series B round

Executive Summary

Biotech immunology company BioXell SPA (spun off from Roche in March 2002) has grossed €17mm ($19.9mm) in its Series B financing. NIB Capital Private led the round and was joined by existing investors MPM Capital, Index Ventures, and Life Sciences Partners, plus new investor Investimenti Piccole.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies